MyDx
MyDx, a handheld analyzer that correlates chemical composition & feeling in cannabis, to enable personalized medicine for everyone
- Stage Product In Development
- Industry Consumer Products
- Location San Diego, CA, USA
- Currency USD
- Website mydx.me
Company Summary
Our goal is to empower the entire industry with the ability to correlate the chemical composition of cannabis with feeling in order to create a better user experience. When presented with a sample of cannabis, MyDx will be able to identify the unique strain and make a recommendation on the feeling it should create. With MyDx, you will be able to track how each strain affects you and create a chemical profile that defines your ideal strain.
Team
-
Daniel Yazbeck leverages his 10+ years of product development experience from Pfizer & Panasonic to support the execution of the MyDx plan at every level. Mr. Yazbeck is also a serial investor & entrepreneur with a focus on identifying promising start-up companies and helping them grow through the Yazbeck Consulting & Investments Group.
-
Skip SanzeriInvestor RelationsOver 100 Startups
Advisors
-
Stubbs, Alderton & Markiles, LLPLawyerUnconfirmed
Wilson Sonsini Goodrich & RosatiSecurities Law FirmUnconfirmed
Previous Investors
-
Yazbeck Consulting & Investments GroupUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.